LobbyingSanotize Research & Development lobbying by quarter
Sanotize Research & Development's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Sanotize Research & Development
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $18K | 1 |
| Q1 2023 | $18K | 1 |
| Q2 2023 | $18K | 1 |
| Q3 2023 | $18K | 1 |
| Q4 2023 | $18K | 1 |
| Q1 2024 | $18K | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$36K · 7 reports
- Health issues$36K · 7 reports
- Medical research and clinical labs$36K · 7 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Defense Threat Reduction Agency (DTRA)7 reports
- HOUSE OF REPRESENTATIVES7 reports
- SENATE7 reports
- Defense, Dept of (DOD)5 reports
- Centers For Disease Control & Prevention (CDC)3 reports
- Centers For Medicare and Medicaid Services (CMS)3 reports
- Defense Advanced Research Projects Agency (DARPA)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| MR. David Gencarelli | $108K | 7 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/22for Q2 2024 | MR. David Gencarelli | Under $5,000 |
| 24/07/22for Q2 2024 | MR. David Gencarelli | $12K |
| 24/05/16for Q1 2024 | MR. David Gencarelli | $18K |
| 24/02/12for Q4 2023 | MR. David Gencarelli | $18K |
| 23/11/24for Q3 2023 | MR. David Gencarelli | $18K |
| 23/07/20for Q2 2023 | MR. David Gencarelli | $18K |
| 23/04/07for Q1 2023 | MR. David Gencarelli | $18K |
| 23/01/19for Q4 2022 | MR. David Gencarelli | $18K |